drugset / Trial / NCT01494753

Pharmacokinetics, Efficacy and Safety Assessment of T2345 Compared With Active Comparator in Newly Diagnosed Patients With Open-angle Glaucoma or Ocular Hypertension

NCT01494753

Phase 2 Completed 30 enrolled Laboratoires Thea
RandomizedCrossoverSingle-blindTreatment

Summary

The purpose of this study is to assess the pharmacokinetics, efficacy and safety of T2345 versus an active comparator.

Timeline

Start
2008-06
Primary completion
2008-12
Completion
2008-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule

Indications